BioNTech SE
BNTX
$93.66
$0.320.34%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -1.44B | -1.26B | -633.26M | -381.92M | -812.62M |
| Total Depreciation and Amortization | 304.22M | 210.06M | 273.71M | 177.32M | 173.15M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 916.07M | 1.02B | -51.82M | -326.57M | -243.38M |
| Change in Net Operating Assets | 1.17B | 648.19M | 174.94M | -1.32B | 616.45M |
| Cash from Operations | 956.15M | 617.72M | -236.43M | -1.85B | -266.41M |
| Capital Expenditure | -211.48M | -197.76M | -195.18M | -233.24M | -297.85M |
| Sale of Property, Plant, and Equipment | 6.49M | 5.18M | 5.23M | 2.17M | 1.82M |
| Cash Acquisitions | 308.25M | 225.64M | -82.61M | -82.61M | -82.61M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1.39B | -3.05B | 1.08B | 2.04B | 1.92B |
| Cash from Investing | -1.29B | -3.02B | 803.92M | 1.73B | 1.54B |
| Total Debt Issued | 45.10M | 6.70M | -- | -- | -- |
| Total Debt Repaid | -55.80M | -57.60M | -45.90M | -42.30M | -51.90M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2.00M | -2.00M | -- | -- | -- |
| Cash from Financing | -14.89M | -59.71M | -50.84M | -46.08M | -55.64M |
| Foreign Exchange rate Adjustments | -16.97M | -30.01M | -17.14M | 5.47M | -8.53M |
| Miscellaneous Cash Flow Adjustments | 35.13M | 8.16M | -18.45M | 23.37M | 59.47M |
| Net Change in Cash | -326.51M | -2.48B | 481.05M | -139.33M | 1.27B |